Related Experiment Video
Updated: Oct 25, 2025
Point-Of-Care Ultrasound Screening for Proximal Lower Extremity Deep Venous Thrombosis
Published on: February 10, 2023
Antithrombotic Therapy for VTE Disease: Second Update of the CHEST Guideline and Expert Panel Report
Scott M Stevens1, Scott C Woller1, Lisa Baumann Kreuziger2
1Department of Medicine, Intermountain Healthcare, Murray, UT.
Insights
This updated guideline provides 29 recommendations on managing venous thromboembolism (VTE), including 13 strong recommendations. New evidence informs care, but uncertainties persist for specific patient groups.
Area of Science:
- Medical Guidelines
- Thrombosis Management
- Evidence-Based Medicine
Background:
- This document represents the second update to the ninth edition of clinical guidelines.
- It addresses 17 Population, Intervention, Comparator, Outcome (PICO) questions relevant to venous thromboembolism (VTE).
- Four PICO questions are newly introduced in this update.
Purpose of the Study:
- To provide updated recommendations for the antithrombotic management of VTE.
- To incorporate new evidence and address previously unexamined aspects of VTE care.
- To guide clinical decision-making from initial VTE management to long-term prevention strategies.
Main Methods:
- Recommendations were developed using the GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) methodology.
- Evidence certainty was categorized as high, moderate, or low to inform recommendation strength.
- Guidance statements were generated based on rigorous review of emerging scientific evidence.
Main Results:
- A total of 29 guidance statements were formulated, with 13 classified as strong recommendations.
- The recommendations cover the spectrum of VTE management, including secondary prevention and postthrombotic syndrome risk reduction.
- Eight statements were significantly revised from the previous update, and four are entirely new.
Conclusions:
- Recent evidence has refined the standard of care for patients with VTE.
- Despite advancements, significant uncertainties remain in managing VTE, particularly in specific patient populations and limited disease scenarios.
- Continued research is needed to address knowledge gaps in VTE management.
Background:
This is the 2nd update to the 9th edition of these guidelines. We provide recommendations on 17 PICO (Population, Intervention, Comparator, Outcome) questions, four of which have not been addressed previously.
Methods:
We generate strong and weak recommendations based on high-, moderate-, and low-certainty evidence, using GRADE (Grading of Recommendations, Assessment, Development, and Evaluation) methodology.
Results:
The panel generated 29 guidance statements, 13 of which are graded as strong recommendations, covering aspects of antithrombotic management of VTE from initial management through secondary prevention and risk reduction of postthrombotic syndrome. Four new guidance statements have been added that did not appear in the 9th edition (2012) or 1st update (2016). Eight statements have been substantially modified from the 1st update.
Conclusion:
New evidence has emerged since 2016 that further informs the standard of care for patients with VTE. Substantial uncertainty remains regarding important management questions, particularly in limited disease and special patient populations.
Related Concept Videos
01:29Venous Thrombosis III: Interprofessional Care
01:29Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
01:27Pulmonary Embolism III: Nursing Management
01:20Venous Thrombosis II: Clinical Manifestations and Diagnostic Studies
01:30Venous Thrombosis IV: Nursing Management
01:26Flail Chest-II
Assessment:
1. Clinical Evaluation:
History: